Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin A3 family member B pseudogene (ELOA3BP, ELOA3P) is a non-coding pseudogene associated structurally with the Elongin A3 gene cluster, a group of primate-specific retrogenes encoding transcription elongation factors related to Elongin A. Unlike the functional ELOA3 protein, which acts as a promoter-associated pause-release factor regulating RNA polymerase II elongation, ELOA3BP does **not encode a functional protein** and is not considered a therapeutic target or direct disease gene. The region is referenced in genomic association studies for certain diseases, but there is no evidence for direct causality or pharmacological relevance. Multiple aliases mix functional and non-functional members of the gene family, but for ELOA3BP itself, the correct designation is as a pseudogene without biological or medical activity[1][3].
null — No mechanism of action applies. For the functional ELOA3 protein, it mediates promoter-associated RNA polymerase II pause release, but the pseudogene does not encode a protein[3].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongin A3 family member B pseudogene (ELOA3BP).